ENDRA Life Sciences Inc. announced its financial results for the quarter ended June 30, 2023 and the submission of a de novo application for its Thermo-Acoustic Enhanced Ultrasound technology to the FDA.
AI Assistant
ENDRA LIFE SCIENCES INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.